In a classic example of how trial results can impact stock prices, shares of Heat Biologics Inc
the other hand,
Recent Stock Performance
Shares of Durham, North Carolina-based Heat Biologics closed Wednesday’s trading at $2.87, while bluebird bio ended trading at $60.35.
In the pre-market hours Thursday, Heat Biologics sank 58 percent to $1.20, while Cambridge, Massachusetts-based bluebird bio surged 22.54 percent to $73.95. Shares of Celegene too gained 1.6 percent to $120.45 on the news.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.